URGN — UROGEN PHARMA LTD

Ownership history in Caption Management, LLC  ·  8 quarters on record

This page tracks every 13F SEC filing in which Caption Management, LLC reported a position in UROGEN PHARMA LTD (URGN). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.16% (2025 Q4)
Avg. % of fund
0.05%
First filed
2023 Q2
Last filed
2025 Q4
Quarters held
8
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 UNCHANGED 1,000,000 — 0% 0.16% $23.4M $23.42
2025 Q3 ADDED 1,000,000 +930,000 +1328.6% 0.16% $19.9M $19.95
2025 Q3 ADDED 70,000 +20,000 +40.0% 0.01% $1.4M $19.95
2025 Q2 REDUCED 50,000 -18,000 -26.5% 0.01% $685K $13.70
4 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    URGN price (monthly, adj. close)

Other funds also holding URGN

As of 2025 Q4 — sorted by position size

ACORN CAPITAL ADVISORS, LLC 11.49% SUPERSTRING CAPITAL MANAGEMENT LP 9.01% SILVERARC CAPITAL MANAGEMENT, LLC 3Y 5.66% Paradigm Biocapital Advisors LP 3Y 2.67% MPM BioImpact LLC 3Y 2.52% RTW INVESTMENTS, LP 3Y 7Y 1.07% Privium Fund Management B.V. 3Y 0.93% Opaleye Management Inc. 3Y 7Y 0.83% Elmind Capital, LP 0.69% TCG Crossover Management, LLC 3Y 0.56%
← Back to Caption Management, LLC Holdings